Clinical Efficacy of MS-1A Fatty Liver Therapy Apparatus in the Treatment of Metabolism-related Fatty Liver Disease

Sun Tianqi; Lu Bingjiu

Abstract：Objective To investigate the clinical efficacy and safety of MS-1A fatty liver therapy apparatus in the treatment of metabolism-related fatty liver disease.Methods 90 patients were divided into treatment group,basic treatment group and drug ad-ministration group by random number table method,with 30 cases in each group.The basic treatment group was only given basic treat-ment with dietary style and exercise lifestyle guidance,and the course of treatment was 12 w;the administration group was treated with Yishanfu oral therapy on the basis of basic treatment,and the course of treatment was 12 w;treatment group was given oral Yishanfu therapy on the basis of basic treatment and MS-1A fatty liver therapy instrument,and the course of treatment was 12 w.BMI and waist-hip ratio of the 3 groups,liver function index(ALT,AST,GGT),blood lipid indexes(TC,TG,HDL-C),and B-ultrasound scores of patients before and after treatment were observed before treatment and after 12 weeks of treatment.Results After 12 w of treatment,the total effective rate of the treatment group was 93.33%,which was higher than that of the basic treatment group(63.33%)and the administration group(80.00%)(P<0.05).Compared with before treatment,after the 12th week of treatment,BMI,waist-to-hip ratio,liver function(ALT,AST,GGT),lipid(TC,TG)indexes and B-ultrasound scores of patients in the 3 groups were all lower than before treatment,and the treatment group was higher than the basic treatment group and drug administra-tion group(P<0.05);compared with before treatment,at the 12th week of treatment,the HDL-C value of the 3 groups was higher than that before treatment,and the treatment group was higher than the basic treatment group and the drug administration group(P<0.05).Conclusion As a new non-invasive treatment method,MS-1A fatty liver therapy apparatus has a significant effect on the clinical treatment of metabolism-related fatty liver disease.At the same time,it plays a good auxiliary role in the drug treatment of liv-er-related diseases,providing a new way for the clinical treatment of metabolism-related fatty liver disease.